| CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy W Wang, M Green, JE Choi, M Gijón, PD Kennedy, JK Johnson, P Liao, ... Nature 569 (7755), 270-274, 2019 | 1932 | 2019 |
| Cancer SLC43A2 alters T cell methionine metabolism and histone methylation Y Bian, W Li, DM Kremer, P Sajjakulnukit, S Li, J Crespo, ZC Nwosu, ... Nature 585 (7824), 277-282, 2020 | 372 | 2020 |
| Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation X Zhang, K Tanaka, J Yan, J Li, D Peng, Y Jiang, Z Yang, MC Barton, ... Proceedings of the National Academy of Sciences 110 (43), 17284-17289, 2013 | 168 | 2013 |
| Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy J Li, W Wang, Y Zhang, M Cieślik, J Guo, M Tan, MD Green, W Wang, ... The Journal of clinical investigation 130 (5), 2712-2726, 2020 | 144 | 2020 |
| Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis HL Franco, A Nagari, VS Malladi, W Li, Y Xi, D Richardson, KL Allton, ... Genome research 28 (2), 159-170, 2018 | 135 | 2018 |
| LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy G Li, I Kryczek, J Nam, X Li, S Li, J Li, S Wei, S Grove, L Vatan, J Zhou, ... Nature cell biology 23 (5), 526-537, 2021 | 116 | 2021 |
| Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance H Lin, I Kryczek, S Li, MD Green, A Ali, R Hamasha, S Wei, L Vatan, ... Cancer cell 39 (4), 480-493. e6, 2021 | 108 | 2021 |
| Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes Y Xi, J Shi, W Li, K Tanaka, KL Allton, D Richardson, J Li, HL Franco, ... BMC genomics 19, 1-11, 2018 | 84 | 2018 |
| TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation J Li, Y Xi, W Li, RL McCarthy, SA Stratton, W Zou, SY Dent, AK Jain, ... Oncogene 36 (21), 2991-3001, 2017 | 76 | 2017 |
| The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity J Zhou, I Kryczek, S Li, X Li, A Aguilar, S Wei, S Grove, L Vatan, J Yu, ... Nature immunology 22 (4), 460-470, 2021 | 72 | 2021 |
| Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells J Li, N Belogortseva, D Porter, M Park Cell cycle 7 (18), 2886-2893, 2008 | 66 | 2008 |
| Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells J Li, B Orr, K White, N Belogortseva, R Niles, G Boskovic, H Nguyen, ... Molecular cancer 8, 1-13, 2009 | 42 | 2009 |
| 单侧输尿管梗阻法制作大鼠肾间质纤维化模型的改进 刘克剑， 张悦， 李靖， 何立群， 韩志芬， 庞惠芳， 徐伟珍 中国实验动物学报 15 (6), 410-412, 2008 | 31 | 2008 |
| 建立教学模拟医院 提高实验教学质量 林梅， 李靖 中国高等医学教育, 82-82, 2006 | 31 | 2006 |
| 丹参酚酸 B 对肾纤维化大鼠肾组织 MNP-2 表达的影响 [J] 陆海英， 张悦， 刘煜敏， 陆敏， 周娟， 刘克剑， 李靖 上海中医药大学学报 23 (2), 55-58, 2009 | 27 | 2009 |
| Chromatin modifying protein 1A (Chmp1A) of the endosomal sorting complex required for transport (ESCRT)-III family activates ataxia telangiectasia mutated (ATM) for PanC-1 cell … S Manohar, M Harlow, H Nguyen, J Li, GR Hankins, M Park Cell Cycle 10 (15), 2529-2539, 2011 | 22 | 2011 |
| 慢性肾功能衰竭中医证型与实验室指标相互关系的研究 李福凤， 王忆勤， 郭丽， 王伟锋， 李靖， 王惠芳， 何立群 上海中医药大学学报 16 (3), 33-36, 2002 | 15 | 2002 |
| Coagulopathy as a prodrome of cytokine storm in COVID-19-infected patients H Guo, Y Sheng, W Li, F Li, Z Xie, J Li, Y Zhu, J Geng, G Liu, LJ Wang, J Li, ... Frontiers in Medicine 7, 572989, 2020 | 13 | 2020 |
| 抗纤灵抗大鼠肾间质纤维化的实验研究 刘煜敏， 张悦， 何立群， 陆海英， 刘克剑， 李靖， 林敏 中国中西医结合杂志 27 (010), 901-904, 2007 | 12 | 2007 |
| 抗纤灵方对单侧输尿管梗阻大鼠 TGF-β1-Smad 通路的影响 刘煜敏， 张悦， 何立群， 刘克剑， 李靖， 陆海英， 韩志芬， 庞慧芳， 林敏 中国病理生理杂志 24 (012), 2423-2427, 2008 | 10 | 2008 |
